These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3894515)

  • 1. Sodium restriction lowers high blood pressure through a decreased response of the renin system--direct evidence using saralasin.
    Cappuccio FP; Markandu ND; Sagnella GA; MacGregor GA
    J Hypertens; 1985 Jun; 3(3):243-7. PubMed ID: 3894515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects.
    Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):48-52. PubMed ID: 1071403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II blockade in patients with essential hypertension.
    MacGregor GA; Dawes PM
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):53-4. PubMed ID: 1071404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II blockade in normal subjects and essential hypertensive patients.
    MacGregor GA; Dawes PM
    Clin Sci Mol Med Suppl; 1976 Dec; 3():193s-196s. PubMed ID: 1071606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pressor response to 1-sar-8-ala-angiotensin II (saralasin) in hypertensive subjects.
    Anderson GH; Streeten DH; Dalakos TG
    Circ Res; 1977 Mar; 40(3):243-50. PubMed ID: 837471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between arterial pressure, dietary sodium intake, and renin system in essential hypertension.
    Parfrey PS; Markandu ND; Roulston JE; Jones BE; Jones JC; MacGregor GA
    Br Med J (Clin Res Ed); 1981 Jul; 283(6284):94-7. PubMed ID: 6789950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the renin-angiotensin system determine the renal and systemic hemodynamic response to sodium in patients with essential hypertension?
    van Paassen P; de Zeeuw D; Navis G; de Jong PE
    Hypertension; 1996 Feb; 27(2):202-8. PubMed ID: 8567042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the angiotensin II antagonist 1-sar-8-ala-angiotensin II in hypertension in man.
    Fagard R; Amery A; Lijnen P; Reybrouck T
    Eur J Clin Invest; 1977 Dec; 7(6):473-9. PubMed ID: 415868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to blockade by saralasin of effect of ACE inhibitors in conscious sodium-restricted dog.
    Zimmerman BG; Goering JL; Raich PC
    Am J Physiol; 1988 Nov; 255(5 Pt 2):F944-52. PubMed ID: 2847552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immediate pressor response to saralasin in man: a test of angiotensin II receptor vacancy.
    Wallace JM; Case DB; Laragh JH; Keim HJ; Drayer JI; Sealey JE
    Circ Res; 1979 Jan; 44(1):38-44. PubMed ID: 214254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II blockade before and after marked sodium depletion in patients with hypertension.
    Van Hoogdalem P; Donker AJ; Leenen FH
    Clin Sci Mol Med; 1978 Jan; 54(1):75-83. PubMed ID: 620496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 1-sar-8-ala-angiotensin II on arterial pressure, renin and aldosterone in hypertension.
    Fagard R; Lijnen P; Amery A; Reybrouck T
    Contrib Nephrol; 1978; 11():175-8. PubMed ID: 699588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II blockade during combined thiazide-beta-adrenoreceptor-blocker treatment.
    Ibsen H; Leth A; McNair A; Giese J
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():123s-125s. PubMed ID: 396064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood-pressure response to moderate sodium restriction and to potassium supplementation in mild essential hypertension.
    Richards AM; Nicholls MG; Espiner EA; Ikram H; Maslowski AH; Hamilton EJ; Wells JE
    Lancet; 1984 Apr; 1(8380):757-61. PubMed ID: 6143083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II blockade in normal man and patients with essential hypertension. Blood pressure effects depending on renin and sodium balance.
    Brunner HR; Gavras H; Ribeiro AB; Posternak L
    Prog Biochem Pharmacol; 1976; 12():145-62. PubMed ID: 1019161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypotensive effects of sodium volume depletion and 1-sar-8-ala-angiotensin II in relation to plasma renin in hypertensive patients.
    Fagard R; Amery A; Lijnen P; Reybrouck T
    Eur J Clin Pharmacol; 1977 Aug; 12(1):1-5. PubMed ID: 902672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of saralasin on normal blood pressure and on reno-vascular hypertension (author's transl)].
    Beckerhoff R; Vetter W; Furrer J; Nussberger J; Schmied U; Siegenthaler W
    Dtsch Med Wochenschr; 1976 Mar; 101(11):398-401. PubMed ID: 1253700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-modulating hypertension: evidence for the involvement of kallikrein/kinin activity associated with overactivity of the renin-angiotensin system. Successful blood pressure control during long-term Na+ restriction.
    Sanchez R; Gimenez MI; Ramos F; Baglivo H; Ramirez AJ
    J Hypertens; 1996 Nov; 14(11):1287-91. PubMed ID: 8934356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of frusemide, saralasin and hypotension on fetal plasma renin activity and on fetal renal function.
    Lumbers ER; Stevens AD
    J Physiol; 1987 Dec; 393():479-90. PubMed ID: 3328781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in plasma norepinephrine after intravertebral artery infusion of saralasin in sodium depleted dogs.
    Arita M; Ueno Y; Suruda H; Mohara O; Nishio I; Masuyama Y
    Jpn Circ J; 1983 Mar; 47(3):336-41. PubMed ID: 6339771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.